The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

Xian Wu,1,* Chaoran Ye,1,* Xingmeng Wang,2 Ruyu Cai,1 Junzhe Yang,1 Xiafei Yu,1 Yi Zhou,1 Li Shen,1 Yanhui Zhu,1 Xiaoan Liu1 1Department of Breast Surgery, The First Affiliated HospitalofNanjing Medical University, Nanjing, 210029, People’s Republic of China; 2Department of General Surgery...

Full description

Bibliographic Details
Main Authors: Wu X, Ye C, Wang X, Cai R, Yang J, Yu X, Zhou Y, Shen L, Zhu Y, Liu X
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:Cancer Management and Research
Subjects:
neoadjuvant chemotherapy
pathological complete response
ec-d
ec-p
toxicity of anticancer drugs
Online Access:https://www.dovepress.com/the-efficacy-and-toxicity-of-neoadjuvant-chemotherapy-regimens-of-epir-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/the-efficacy-and-toxicity-of-neoadjuvant-chemotherapy-regimens-of-epir-peer-reviewed-article-CMAR

Similar Items